Individuals exhibiting heightened MyD88 expression displayed a tumor microenvironment that fosters immune activity, marked by an upsurge in immune cells that suppress cancer, such as M1 macrophages, and a concurrent reduction in those that may promote cancer development, including M2 macrophages. The gene discussed is MYD88; the disease is cancer.